1. Food and Drug Administration. FDA approves first gene therapy to treat adults with hemophilia B. Nov 2022. https://www.fda.gov/news-events/press-announcements/fda-approves-first-gene-therapy-treat-adults-hemophilia-b.
2. US Food and Drug Administration approves CSL’s Hemgenix (etranacogene dezaparvovec-drib), first gene therapy for hemophilia B [press release]. CSL. Nov 2022. https://www.csl.com/news/2022/fda-hemgenix.